MCT Oil in viral respiratory tract infection in patient with metabolic syndrome

Investigating the effects of oral medium-chain triglyceride (MCT) on the process of disease symptoms in patients with viral respiratory tract infection in outpatients with metabolic syndrome

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20201019049079N1

Enrollment

Registered

2021-07-03

Start date

2021-06-05

Completion date

Unknown

Last updated

2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: COVID-19. Condition 2: Seasonal Influenza. Condition 3: Adult Cold. Other coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention 1: Intervention group: To determine the effect of the substance mentioned in the text of Take 2 tablespoons of Medium-Chain Triglyceride oil after each meal for 7 days, and after this Act

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Informed consent Metabolic Syndrome as defined by the International Diabetes Federation (IDF): Abdominal obesity above 94 cm in men and 80 cm in women plus two of the following criteria: IFG above 100, triglyceride above 150, HDL below 40 in men and below 50 in women And have systolic blood pressure above 130 mmHg or diastole above 85 mmHg Symptoms of viral respiratory tract infection

Exclusion criteria

Exclusion criteria: Drug allergy Pregnancy / breastfeeding Asthma and allergies CHF CRF malignancy Immune system defects such as AIDS and corticosteroids

Design outcomes

Primary

Measure	Time frame
Symptoms of viral respiratory tract infection (fever, cough, body aches, shortness of breath). Timepoint: Days 0 (visit day) ,1,2,3,4,7 and 14. Method of measurement: Questionnaire and question from the patient.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Amin Fallah Mehrizi

Kerman University of Medical Sciences

amin.fallah44@gmail.com+98 34 3325 7660

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026